Focus: Dexcom is a San Diego-based medical device company founded in 1999 specializing in continuous glucose monitoring (CGM) systems for diabetes management. The company is a market leader in real-time glucose monitoring technology with an expanding portfolio of devices and integrated solutions.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Hot — 294 jobs added in 30d
Net +75 (294 new, 219 removed). Aggressive expansion phase.
Best fit for device engineers, commercial operations, and manufacturing professionals; limited appeal for clinical development or early-stage research scientists seeking traditional pharma career tracks.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dexcom
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Dexcom's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
+1 more
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo